Hongbing Chen - China Medical President
| CHSYFDelisted Stock | USD 0.93 0.00 0.00% |
President
Mr. Chen Hongbing serves as Chief Operating Officer, Vice President, Executive Director of China Medical System Holdings Limited. Mr. Chen was appointed as an executive Director on 18 December 2006. He joined the Group in 1995 and has remained with the Group since then since 2006.
| Age | 56 |
| Tenure | 18 years |
| Professional Marks | Ph.D |
| Phone | 852 2369 7678 |
| Web | https://www.cms.net.cn |
China Medical Management Efficiency
The company has return on total asset (ROA) of 0.1324 % which means that it generated a profit of $0.1324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.243 %, meaning that it generated $0.243 on every $100 dollars invested by stockholders. China Medical's management efficiency ratios could be used to measure how well China Medical manages its routine affairs as well as how well it operates its assets and liabilities.China Medical System has accumulated 573.81 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. China Medical System has a current ratio of 3.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist China Medical until it has trouble settling it off, either with new capital or with free cash flow. So, China Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medical System sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Hafrun Fridriksdottir | Teva Pharma Industries | 58 | |
| Sven Dethlefs | Teva Pharma Industries | 55 | |
| Majda Labadi | Hikma Pharmaceuticals PLC | N/A | |
| Mark Sabag | Teva Pharma Industries | 53 | |
| Etienne Montagut | Lantheus Holdings | 49 | |
| Susan Ringdal | Hikma Pharmaceuticals PLC | N/A | |
| Eliyahu Kalif | Teva Pharma Industries | 51 | |
| Jeffrey Jacobson | Cronos Group | 38 | |
| Tyler Robson | SNDL Inc | 35 | |
| Kathleen Veit | Teva Pharma Industries | N/A | |
| Navroop Sandhawalia | SNDL Inc | ||
| Ganadhish Kamat | Dr Reddys Laboratories | 57 | |
| MPharm MS | Dr Reddys Laboratories | 61 | |
| Saumen Chakraborty | Dr Reddys Laboratories | 58 | |
| Brendan OGrady | Teva Pharma Industries | 53 | |
| Marcie Kiziak | SNDL Inc | 44 | |
| David Stark | Teva Pharma Industries | 55 | |
| Gianfranco Nazzi | Teva Pharma Industries | 50 | |
| Riad Mishlawi | Hikma Pharmaceuticals PLC | N/A | |
| Stephen Carey | ANI Pharmaceuticals | 53 | |
| Carol Walker | Lantheus Holdings | 61 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 |
China Medical System Leadership Team
Elected by the shareholders, the China Medical's board of directors comprises two types of representatives: China Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medical's management team and ensure that shareholders' interests are well served. China Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanling Chen, CFO, Vice-Pres and Executive Director | ||
| Wai Wong, Chief Technical Officer | ||
| Kong Lam, Founder, Chairman of The Board, CEO and Member of Nomination Committee | ||
| Sanyan Wu, Company Secretary | ||
| Hongbing Chen, COO, Vice-President, Director of Sales and Marketing and Executive Director |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.37 % | |||
| Current Valuation | 3.84 B | |||
| Shares Outstanding | 2.45 B | |||
| Shares Owned By Insiders | 49.55 % | |||
| Shares Owned By Institutions | 19.25 % | |||
| Price To Earning | 8.10 X | |||
| Price To Book | 1.71 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |